Recruiting Bladder Cancer Studies in Denver
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
This is a global, multicenter, randomized, open-label study, with an adaptive design. The main objective of the study is to measure the efficacy and safety of BT8009 (zelenectide pevedotin) as monothe...
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
This study is a Phase I/II, multicenter, first-in-human, open-label dose-escalation study of BT8009 given as a single agent and in combination with pembrolizumab in participants with advanced solid tu...
About Bladder Cancer Clinical Trials in Denver
Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.
There are currently 2 bladder cancer clinical trials recruiting participants in Denver, CO. These studies are seeking a combined 1,285 participants. Research is being sponsored by BicycleTx Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.
Bladder Cancer Clinical Trials in Denver — FAQ
Are there bladder cancer clinical trials in Denver?
Yes, there are 2 bladder cancer clinical trials currently recruiting in Denver, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Denver?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.
Are clinical trials in Denver free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.
What bladder cancer treatments are being tested?
The 2 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for bladder cancer.
Data updated March 2, 2026 from ClinicalTrials.gov